Cardiac ischemia causes inhibition of the Na/K ATPase by a labile cytosolic compound whose production is linked to oxidant stress

Cardiovasc Res. 2003 Mar 15;57(4):1044-51. doi: 10.1016/s0008-6363(02)00810-6.

Abstract

Objective: Intracellular Na rises rapidly during cardiac ischemia and this has been attributed to the combination of increased influx of Na via sodium-proton exchange and decreased activity of the Na/K ATPase. The aim of these studies was to investigate the effects of ischemia on Na/K ATPase function in Langendorff-perfused rat hearts.

Methods: Na/K ATPase activity was determined by measuring ouabain-sensitive phosphate generation from ATP by cardiac homogenates.

Results: Global ischemia (15 and 30 min) caused a substantial reduction in Na/K ATPase function despite high substrate availability in the assay. When sarcolemmal membranes were purified away from the cytosol a profound activation of the Na/K ATPase was revealed following ischemia, indicating that the inhibition was due to the cytosolic accumulation of an inhibitor of Na/K ATPase. The half-life of the inhibitor in cardiac homogenates was 10+/-3 min at room temperature. Perfusion with the antioxidant MPG (1 mmol/l) reduced the accumulation of this inhibitor, however MPG was without effect on Na/K ATPase function when added directly to the Na/K ATPase activity assay. While the inhibitor reduced the activity of cardiac and brain forms of the Na/K ATPase in bioassay experiments, no effect was observed on the renal and skeletal muscle forms of the enzyme.

Conclusions: An unstable cardiac and brain-specific inhibitor of the Na/K ATPase whose production is linked to oxidant stress, accumulates intracellularly during ischemia. Intracellular Na is a primary determinant of electro-mechanical recovery on reperfusion, so inhibition of the Na/K ATPase by this compound may be crucial in determining recovery from ischemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Biological Assay
  • Biological Factors / pharmacology
  • Cytosol / metabolism
  • Enzyme Inhibitors / pharmacology
  • Glycine / analogs & derivatives*
  • Glycine / pharmacology
  • Male
  • Myocardial Ischemia / enzymology*
  • Organ Culture Techniques
  • Ouabain / pharmacology
  • Oxidative Stress
  • Rats
  • Rats, Wistar
  • Sarcolemma / enzymology
  • Sodium-Potassium-Exchanging ATPase / antagonists & inhibitors*
  • Sodium-Potassium-Exchanging ATPase / drug effects
  • Sodium-Potassium-Exchanging ATPase / metabolism
  • Sulfhydryl Compounds / pharmacology

Substances

  • Antioxidants
  • Biological Factors
  • Enzyme Inhibitors
  • N-(2-mercaptoproprionyl)-glycine
  • Sulfhydryl Compounds
  • Ouabain
  • Sodium-Potassium-Exchanging ATPase
  • Glycine